Test-system for estimation of activity of GSK-3 inhibitors as antihypoxants and differentiation of endothelial progenitors in vitro
DOI:
https://doi.org/10.18413/2313-8971-2016-2-1-58-62Аннотация
A model test-system was developed for validation in vitro of antihypoxic and endothelio-differentiating activity of newly created glycogen synthase kinase-3 inhibitors in comparison with the reference drug β4-thymosin.
Ключевые слова:
glycogen synthase kinase-3, GSK-3; β4-thymosin, hypoxia, ischemia, endotheliumЗагрузки
Опубликован
Как цитировать
Выпуск
Раздел
Лицензия
Copyright (c) 2016 Research Results in Pharmacology
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.